OLSON ERIC R (Chief Scientific Officer) sold 9.4% of their position (689.00 shares) of SYROS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/18/2023ACC: 0001209191-23-042669
Officer· Chief Scientific Officer
Since Feb 2019
-689.00
Net shares
Net seller
$2.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
689.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−689.00
Price / share
$3.50
Trade value
$2.41K
% of position
9.4%
7/17/2023
7.35K→6.66K
Total
Net shares
−689.00
Net value
-$2.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/17/2023 | S · Sale | −689.00 | $3.50 | $2.41K | 9.4% | 7.35K | 6.66K |
| Total | −689.00 | -$2.41K | ||||||
Derivative Transactions0
No derivative transactions reported